Calamari Christopher J. 4
4 · ABBOTT LABORATORIES · Filed Feb 23, 2022
Insider Transaction Report
Form 4
Calamari Christopher J.
SENIOR VICE PRESIDENT
Transactions
- Award
Option (right to buy)
2022-02-18+59,708→ 59,708 totalExercise: $117.58From: 2023-02-18Exp: 2032-02-17→ Common Shares (59,708 underlying) - Award
Common shares without par value
2022-02-18+12,812→ 28,732 total
Holdings
- 30,193(indirect: By Trust)
Common shares without par value
- 101(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2022.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 19,902 on February 18, 2023, 19,903 on February 18, 2024 and 19,903 on February 18, 2025.